MRD Testing in Breast Cancer: ASBrS 2025 Impact ASBrS 3 Mins Read At ASBrS 2025, experts showcased how MRD testing in breast cancer is revolutionizing patient care. Using Natera’s Signatera, clinicians detect circulating tumor…
FGFR2 Mutations and IDH1 Real-World Data Suggests Caution with Immunotherapy in Specific mBTC – ASCO GI Dr. Richard Kim, MD Moffitt Cancer Center Gastrointestinal Cancer Treatment 3 Mins Read In the rapidly evolving field of cancer treatment, the application of comprehensive genomic profiling (CGP) via liquid biopsy has become…
